30 results
Prosecution First Blog
Means-Plus-Function and Step-Plus-Function Claim Limitations (35 U.S.C. 112(f)): Memo to Examiners from the USPTO Means-Plus-Function and Step-Plus-Function Claim Limitations (35 U.S.C. 112(f)): Memo to Examiners from the USPTO
May 3, 2024
Federal Circuit IP Blog
When to Consider Expert Testimony for Special Purpose Computer-Implemented Means-Plus-Function Claims When to Consider Expert Testimony for Special Purpose Computer-Implemented Means-Plus-Function Claims
October 20, 2023
Prosecution First Blog
Life Sciences Patent Drafting Tool: MPF Claims Life Sciences Patent Drafting Tool: MPF Claims
September 15, 2023
Event
Means–Plus–Function and Antibody Patent Claims: Preparing, Defending, and Enforcing MPF Claims Means–Plus–Function and Antibody Patent Claims: Preparing, Defending, and Enforcing MPF Claims
September 14, 2023
Webinar
At the PTAB Blog
Bringing Down the IPR Petition: Lack of Specification Citations Proves Fatal in Addressing Means-Plus-Function Claims Bringing Down the IPR Petition: Lack of Specification Citations Proves Fatal in Addressing Means-Plus-Function Claims
May 2, 2023
At the PTAB Blog
The Board Denied Institution Due to Petitioner’s Admission that Its Proposed Structure for a Means-Plus Function Limitation Was Incorrect The Board Denied Institution Due to Petitioner’s Admission that Its Proposed Structure for a Means-Plus Function Limitation Was Incorrect
April 11, 2023
Articles
Latest Developments in IP Strategies for Pharmaceuticals Latest Developments in IP Strategies for Pharmaceuticals
Summer 2022
International Pharmaceutical IndustryFederal Circuit IP Blog
District Court’s Failure to Consider Unrebutted Expert Testimony and Surrounding Claim Context Fatal to Means-Plus-Function Analysis District Court’s Failure to Consider Unrebutted Expert Testimony and Surrounding Claim Context Fatal to Means-Plus-Function Analysis
April 6, 2022
1 result
Media Mention
The Biggest Patent Cases of 2015 The Biggest Patent Cases of 2015
December 14, 2015
Law360Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.